Home  >  Suppliers  >  Creative Bioarray

Filter your search

Clear All Filters / Fresh Search

Sale Labsave Facebook Like Us Biosave Biosave Filter Newsletter Signup Filter

Creative Bioarray

Supplier Rating:
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 Reviews
IST-MEL1
IST-MEL1
Creative Bioarray

Species: human, Caucasian male adult; Tissue: skin; Tumor: melanoma

RS-5
RS-5
Creative Bioarray

Established in 2003 from the untreated malignant mesothelioma of the pleura of a 78-year-old man with asbestos cancer

JL-1
JL-1
Creative Bioarray

Established from the untreated malignant epithelioid mesothelioma of the pleura of a 54-year-old man with asbestos cancer in 2003

DM-3
DM-3
Creative Bioarray

Established from a pleural biopsy of a 62-year-old man with malignant mesothelioma

HBE135-E6E7
HBE135-E6E7
Creative Bioarray

The HBE135-E6E7 cell line was derived from normal bronchial epithelium taken from a man undergoing lobectomy for squamous cell carcinoma.

MOR/CPR
MOR/CPR
Creative Bioarray

MOR/CPR has been developed by growing the parent line, MOR, in increasing concentrations of cisplatin. The cells are cross-resistant to melphalan but show...

MOR/0.4R
MOR/0.4R
Creative Bioarray

MOR/0.4R has been developed from the parent line, MOR, by continuous exposure to increasing concentrations of doxorubicin (also known as adriamycin). This...

MOR/0.2R
MOR/0.2R
Creative Bioarray

The drug resistant cell line MOR/0.2R has been derived from the parent line, MOR, by continuous exposure to increasing concentrations of doxorubicin (also...

MOR
MOR
Creative Bioarray

A human lung adenocarcinoma cell line - parent to various drug resistant MOR cell lines also available, i.e. MOR/0.2R, MOR/0.4R and MOR/CPR.

COR-L23/R23-
COR-L23/R23-
Creative Bioarray

The revertant lung cancer cell line COR-L23/R23- was generated by growing the doxorubicin-selected, resistant variant COR-L23/R without drug exposure for...

COR-L23/R
COR-L23/R
Creative Bioarray

The cell line COR-L23/R is a multi-drug resistant (MDR) sub-line derived from the parent line COR-L23 after treatment with doxorubicin (adriamycin). The...

COR-L23/CPR
COR-L23/CPR
Creative Bioarray

The cell line COR-L23/CPR is a drug-resistant variant of COR-L23. The line was developed by growing the parent line in increasing concentrations of...

COR-L23/5010
COR-L23/5010
Creative Bioarray

COR-L23/5010 has been derived from the parent line, COR-L23 by continuous exposure to increasing concentrations of doxorubicin (also known as adriamycin)....

NCI-H727
NCI-H727
Creative Bioarray

Species: human, Caucasian female 65 years old; Tissue: lung; Tumor: carcinoma, non small cell

NCI-H292
NCI-H292
Creative Bioarray

Species: human, Black female 32 years old; Tissue: lung; Tumor: carcinoma, mucoepidermoid; Derived from: lymph node metastasis

NCI-H1975
NCI-H1975
Creative Bioarray

Species: human female; Tissue: lung; Tumor: adenocarcinoma, non-small cell

NCI-H1650
NCI-H1650
Creative Bioarray

Species: human, Caucasian male 27 year old; Tissue: lung; Tumor: adenocarcinoma, bronchioalveolar carcinoma; Derived from: pleural effusion

NCI-H460
NCI-H460
Creative Bioarray

Established in 1982 from the pleural fluid of a patient with large cell carcinoma of the lung

NCI-H510A
NCI-H510A
Creative Bioarray

Established in 1982 from an adrenal gland metastasis of a small cell lung cancer from a man in relapse following treatment; cells were described to be...

NCI-H82
NCI-H82
Creative Bioarray

The NCI-H82 cell line was derived by A.F. Gazdar and associates in 1978 from the pleural fluid of a patient with small cell cancer of the lung. The...

Button_on Button_off_biosave Button_off_biosave Button_off_biosave Button_off_biosave Button_off_biosave Button_off_biosave